{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:22:58Z","timestamp":1753885378773},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Systemic Epstein-Barr virus<jats:sup>+<\/jats:sup>T-cell lymphoma (sEBV<jats:sup>+<\/jats:sup>TCL) occurs in childhood and young adults, and is exceptionally rare in older adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated clinicopathological features in 16 patients of various ages with systemic EBV<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>T-lymphoproliferative diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight younger patients and four of eight older adults had sEBV<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>TCL, with invasion by medium-sized to\/or large atypical lymphocytes primarily in bone marrow and lymph nodes, hemophagocytic lymphohistiocytosis (HLH), and progressive clinicopathological course. A further two patients demonstrated EBV<jats:sup>+<\/jats:sup>node-based CD8<jats:sup>+<\/jats:sup>large TCL without HLH, while the remaining two had the systemic form of chronic active EBV infection (sCAEBV) with CD8<jats:sup>+<\/jats:sup>small lymphocytes. Past history of sCAEBV-like lesions was observed in one sEBV<jats:sup>+<\/jats:sup>TCL patient (8.3%). Immunohistologically, in 12 sEBV<jats:sup>+<\/jats:sup>TCL patients, atypical lymphocytes were positive for phosphate signal transducer and activator of transcription 3 (66.7%), CMYC (83.3%), and p53 (75%). Strong reactions of programmed cell death-ligand (PD-L)1<jats:sup>+<\/jats:sup>tumor or non-neoplastic cells were detected in nine sEBV<jats:sup>+<\/jats:sup>TCL patients (75%). Clonal peaks of the T-cell receptor (<jats:italic>TCR) \u03b3<\/jats:italic>gene were detected in eight sEBV<jats:sup>+<\/jats:sup>TCL patients by polymerase chain reaction. Four younger patients in sEBV<jats:sup>+<\/jats:sup>TCL (33.3%) are in remission with chemotherapies including etoposide, and three of the four underwent allogeneic stem cell transplantation (SCT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>sEBV<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>TCL was observed in younger and older adults with less history of sCAEBV. HLH, tumor cell atypia, immunohistological findings, and progressive clinical course were characteristic of sEBV<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>TCL. Prompt chemotherapy and SCT induced tumor regression in sEBV<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup>TCL patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13000-021-01107-1","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T09:03:13Z","timestamp":1622797393000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults"],"prefix":"10.1186","volume":"16","author":[{"given":"Ziyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Gamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Makihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Daa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Momosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"2","key":"1107_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, et al. Fulminant EBV+ T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000;96(2):443\u201351. https:\/\/doi.org\/10.1182\/blood.V96.2.443.","journal-title":"Blood"},{"key":"1107_CR2","first-page":"355","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"L Quintanilla-Martinez","year":"2017","unstructured":"Quintanilla-Martinez L, Ko YH, Kimura H, Jaffe ES. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. revised 4th ed. Lyon: IARC Press; 2017. p. 355\u201360.","edition":"revised 4th ed"},{"issue":"1","key":"1107_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","volume":"37","author":"IA Montes-Mojarro","year":"2020","unstructured":"Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. Epstein-Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis. Semin Diagn Pathol. 2020;37(1):32\u201346. https:\/\/doi.org\/10.1053\/j.semdp.2019.12.004.","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"1107_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673\u201386. https:\/\/doi.org\/10.1182\/blood-2011-10-381921.","journal-title":"Blood"},{"issue":"5","key":"1107_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12185-019-02612-2","volume":"109","author":"R Yanagaisawa","year":"2019","unstructured":"Yanagaisawa R, Matsuda K, Ohga S, Kanegane H, Morimoto A, Okamoto Y, et al. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol. Int J Hematol. 2019;109(5):612\u20137. https:\/\/doi.org\/10.1007\/s12185-019-02612-2.","journal-title":"Int J Hematol"},{"issue":"7","key":"1107_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/pbc.24980","volume":"61","author":"K Kogawa","year":"2014","unstructured":"Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan histiocytosis study group. Pediatr Blood Cancer. 2014;61(7):1257\u201362. https:\/\/doi.org\/10.1002\/pbc.24980.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"1107_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198803243181203","volume":"318","author":"JF Jones","year":"1988","unstructured":"Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic active Epstein-Barr virus infections. N Engl J Med. 1988;318(12):733\u201341. https:\/\/doi.org\/10.1056\/NEJM198803243181203.","journal-title":"N Engl J Med"},{"issue":"6","key":"1107_CR8","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/blood.V91.6.2085","volume":"91","author":"H Kanegane","year":"1998","unstructured":"Kanegane H, Bhatia K, Gutierrez M, Kaneda H, Wada T, Yachie A, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 1998;91(6):2085\u201391. https:\/\/doi.org\/10.1182\/blood.V91.6.2085.","journal-title":"Blood"},{"issue":"4","key":"1107_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/25785826.2018.1556030","volume":"41","author":"A Arai","year":"2018","unstructured":"Arai A. Chronic active Epstein-Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements. Immunol Med. 2018;41(4):162\u20139. https:\/\/doi.org\/10.1080\/25785826.2018.1556030.","journal-title":"Immunol Med"},{"issue":"8","key":"1107_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/PAS.0000000000001495","volume":"44","author":"Z Chen","year":"2020","unstructured":"Chen Z, Wang M, Guan P, Zhao S, Zhang W, Gao L, et al. Comparison of systemic EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood based on classification evolution: new classification, old problems. Am J Surg Pathol. 2020;44(8):1061\u201372. https:\/\/doi.org\/10.1097\/PAS.0000000000001495.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1107_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","volume":"39","author":"S Kato","year":"2015","unstructured":"Kato S, Asano N, Miyata-Takata T, Takata K, Elsayed AA, Satou A, et al. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL). A clinicopathologic study of 39 cases. Am J Surg Pathol. 2015;39(4):462\u201371. https:\/\/doi.org\/10.1097\/PAS.0000000000000323.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1107_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","volume":"46","author":"YK Jeon","year":"2015","unstructured":"Jeon YK, Kim JH, Sung JY, Han JH, Ko YH. Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol. 2015;46(7):981\u201390. https:\/\/doi.org\/10.1016\/j.humpath.2015.03.002.","journal-title":"Hum Pathol"},{"key":"1107_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fped.2019.00071","volume":"7","author":"WY Kim","year":"2019","unstructured":"Kim WY, Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. Epstein-Barr virus-associated T and NK-cell Lymphoproliferative diseases. Front Pediatr. 2019;7:71. https:\/\/doi.org\/10.3389\/fped.2019.00071.","journal-title":"Front Pediatr"},{"key":"1107_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","volume":"58","author":"K Ohshima","year":"2008","unstructured":"Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee S-S, et al. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008;58:209\u201317.","journal-title":"Pathol Int"},{"issue":"16","key":"1107_CR15","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna SW, Marsh RA. Pediatric hemophagocytic lymphohistiocytosis. Blood. 2020;135(16):1332\u201343. https:\/\/doi.org\/10.1182\/blood.2019000936.","journal-title":"Blood"},{"issue":"7","key":"1107_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/his.12882","volume":"68","author":"D Kwon","year":"2016","unstructured":"Kwon D, Kim S, Kim PJ, Go H, Nam SJ, Paik JH, et al. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas. Histopathology. 2016;68(7):1079\u201389. https:\/\/doi.org\/10.1111\/his.12882.","journal-title":"Histopathology"},{"issue":"12","key":"1107_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17(12):2257\u2013317. https:\/\/doi.org\/10.1038\/sj.leu.2403202.","journal-title":"Leukemia"},{"issue":"2","key":"1107_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00428-008-0640-7","volume":"453","author":"S Park","year":"2008","unstructured":"Park S, Kim K, Kim WS, Yoo KH, Koo HH, Ko YH. Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients. Virchows Arch. 2008;453(2):155\u201363. https:\/\/doi.org\/10.1007\/s00428-008-0640-7.","journal-title":"Virchows Arch"},{"issue":"1\u201312","key":"1107_CR19","doi-asserted-by":"crossref","first-page":"e27798","DOI":"10.1002\/pbc.27798","volume":"66","author":"AM Coffey","year":"2019","unstructured":"Coffey AM, Lewis A, Marcogliese AN, Elghetany MT, Punia JN, Chang CC, et al. A clinicopathologic study of the spectrum of systemic forms of EBV-associated T-cell lymphoproliferative disorders of childhood: a single tertiary care pediatric institution experience in North America. Pediatr Blood Cancer. 2019;66(1\u201312):e27798.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1107_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/10428194.2016.1179297","volume":"58","author":"JH Paik","year":"2017","unstructured":"Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, et al. Clinicopathological categorization of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017;58(1):53\u201363. https:\/\/doi.org\/10.1080\/10428194.2016.1179297.","journal-title":"Leuk Lymphoma"},{"issue":"35","key":"1107_CR21","doi-asserted-by":"publisher","first-page":"59977","DOI":"10.18632\/oncotarget.19230","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Xiong L, Tang W, Zhou Y, Li F. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that need more attentions. Oncotarget. 2017;8(35):59977\u201385. https:\/\/doi.org\/10.18632\/oncotarget.19230.","journal-title":"Oncotarget"},{"issue":"57","key":"1107_CR22","doi-asserted-by":"publisher","first-page":"31077","DOI":"10.18632\/oncotarget.25780","volume":"9","author":"E Onozawa","year":"2018","unstructured":"Onozawa E, Shibayama H, Takada H, Imadome KI, Aoki S, Yoshimori M, et al. STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target. Oncotarget. 2018;9(57):31077\u201389. https:\/\/doi.org\/10.18632\/oncotarget.25780.","journal-title":"Oncotarget"},{"issue":"2","key":"1107_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","volume":"103","author":"SB Ng","year":"2018","unstructured":"Ng SB, Chung TH, Kato S, Nakamura S, Takahashi E, Ko YH, et al. Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica. 2018;103(2):278\u201387. https:\/\/doi.org\/10.3324\/haematol.2017.180430.","journal-title":"Haematologica"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01107-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01107-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T14:05:46Z","timestamp":1699106746000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01107-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1107"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01107-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Fukuoka University, Faculty of Medicine (U-20-05-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare they have no significant relationships with, or financial interest in, any commercial activities pertaining to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}